Comment on "Are inflammatory and malnutrition markers associated with metabolic syndrome in patients with sarcoidosis?"
Tu, Juncai; Li, Xiaofei.
Rev. Assoc. Med. Bras. (1992)
; 68(7): 879-879, July 2022.
Artículo en Inglés |
LILACS-Express
| ID: biblio-1394579
Documentos relacionados
Critical Care of Patients With Cardiopulmonary Complications of Sarcoidosis.
Clinical significance of serum autoantibodies in patients with sarcoidosis.
[Cardiac sarcoidosis: a diagnostic and therapeutic challenge].
Diversity and disparity in the treatment and care of sarcoidosis.
ERS clinical practice guidelines on treatment of sarcoidosis.
Sarcoidosis and autoimmune diseases: differences, similarities and overlaps.
Monocytes in sarcoidosis are potent tumour necrosis factor producers and predict disease outcome.
Single-cell and spatial transcriptomics reveal aberrant lymphoid developmental programs driving granuloma formation.
Drug-induced comorbidities in patients with sarcoidosis.
New molecular targets for the treatment of sarcoidosis.